Below are some of the most frequently asked questions about Pfenex Inc. If you don’t find what you’re looking for here, please contact us directly.
You can view information on our platform and programs by visiting the “Product Pipeline” section of our website.
For media inquiries please send an email to firstname.lastname@example.org.
You can view our recent press releases by visiting the “Newsroom” section of our website.
Quarterly & Annual Reports and other investor materials are available under “Financials & Filings” of the “Investor Relations” section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC atwww.sec.gov.
You must send both your old and new addresses to our transfer agent, American Stock Transfer,http://www.amstock.com/main/nav_contactUs.asp, by U.S. mail. Each stockholder in question must sign the request for an address change.
Please contact our transfer agent at: http://www.amstock.com/main/nav_contactUs.asp. The company can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
Pfenex’s transfer agent is American Stock Transfer and Trust Company, LLC (AST). You can find more information about how to contact AST at: http://www.amstock.com/main/nav_contactUs.asp.
PI 717071 104
Currently, Pfenex does not offer a dividend or a dividend reinvestment program.
Pfenex does not offer a direct stock purchase plan.
Shares can be purchased through a stockbroker of your choice.
Pfenex went public on July 24, 2014.
Pfenex is traded on the New York Stock Exchange under the symbol “PFNX”.
Haskell & White LLP
You can view our management team by visiting the “Senior Management” section of our website.
You can view our Board of Directors by visiting the “Board of Directors” section of our website.
10790 Roselle Street
San Diego, CA 92121
Phone: (858) 352-4400
Pfenex was incorporated in the state of Delaware in November 2009.
Pfenex was founded in 2009.
For investor related questions please send an email email@example.com
Please visit the “Investor Relations” section of our corporate website and choose “Email Alerts” to be added to the Pfenex distribution list.
Please visit “Contact Us” and fill out our web form.